Genelux (GNLX) EBT (2022 - 2026)
Genelux's (GNLX) quarterly EBT came in at -$9.3 million in Q1 2026, down 21.02% year-on-year from -$11.8 million in Q1 2025, and up 89.37% quarter-over-quarter from -$87.8 million in Q4 2025.
Genelux (GNLX) EBT (2022 - 2026) Analysis & Trends
Genelux's EBT history runs 5 years deep, the most recent figure standing at -$9.3 million for Q1 2026.
- On a quarterly basis, EBT fell 21.02% year-over-year to -$9.3 million in Q1 2026; TTM through Mar 2026 was -$116.5 million, a 278.33% decrease from a year earlier, with the FY2025 full-year figure at -$111.0 million, down 21.05% from the prior year.
- EBT grew to -$9.3 million in Q1 2026 per GNLX's latest filing, from -$87.8 million in the prior quarter.
- Across five years, EBT topped out at $6.0 million in Q3 2022 and bottomed at -$117.2 million in Q2 2023.
- The 5-year median for EBT is -$8.1 million (2025), against an average of -$19.5 million.
- Across the five-year window, EBT surged 94.26% in 2024 and sank 828.27% in 2025, its largest moves.
- Year by year, EBT stood at -$3.5 million in 2022, then sank by 93.62% to -$6.8 million in 2023, then tumbled by 39.78% to -$9.5 million in 2024, then sank by 828.27% to -$87.8 million in 2025, then soared by 89.37% to -$9.3 million in 2026.
- Per Business Quant, the three latest GNLX EBT figures stand at -$9.3 million (Q1 2026), -$87.8 million (Q4 2025), and -$11.3 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.31 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 259.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 541.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -453.82 Mn |
| 10 | Genelux | 129.36 Mn | 129.36 Mn | - | -9.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.33 Mn |
| Dec 31, 2025 | -87.81 Mn |
| Sep 30, 2025 | -11.28 Mn |
| Jun 30, 2025 | -8.06 Mn |
| Mar 31, 2025 | -7.71 Mn |
| Dec 31, 2024 | -9.46 Mn |
| Sep 30, 2024 | -6.89 Mn |
| Jun 30, 2024 | -6.73 Mn |
| Mar 31, 2024 | -9.50 Mn |
| Dec 31, 2023 | -6.77 Mn |
| Sep 30, 2023 | -5.35 Mn |
| Jun 30, 2023 | -117.16 Mn |
| Mar 31, 2023 | -9.57 Mn |
| Dec 31, 2022 | -3.50 Mn |
| Sep 30, 2022 | 6.01 Mn |